Kinases are a protein family playing a critical role in signal transduction which underlie many cellular processes. PamGene’s functional kinase assay is activity-based and detects protein kinase activity directly in cellular and tissue lysates, through measuring peptide phosphorylation by protein kinases.
Our technology opens up opportunities for a wide range of rapid and non-invasive applications. It is currently applied in the areas of fundamental science, translational research and diagnostics. PamGene’s technology is used to gain insights into discriminative drug responses, analyzing and optimizing kinase inhibitors and discovery of novel biomarkers, targets and pathways.
Fluorescently labelled anti-phospho antibodies are used to detect phosphorylation activity of kinases present in the sample. The sample consisting of protein and labelled antibodies are dispensed onto the PamChip, which is placed in the PamStation. Once inside the instrument the sample is incubated at a predetermined temperature. During incubation the sample is pumped back and forth through the porous material to maximize binding kinetics and minimize assay time. Reaction times are typically minutes to an hour. Upon wetting, the surface material of the PamChip microarrays becomes translucent, facilitating imaging using a LED imaging system.
PTK Assay
Kinase(s) in the sample (recombinant, cell or tissue lysate) actively phosphorylate substrates on the PamChip®, in the presence of ATP. A FITC-conjugated PY20 antibody, present in the reaction mix is used to detect the phosphorylated Tyr to quantify the phosphorylation signal. Images are taken every 5 minutes to generate real time kinetics data.
STK Assay
Kinase(s) in the sample (recombinant, cell or tissue lysate) actively phosphorylate substrates on the PamChip®, in the presence of ATP. An antibody mix is used to detect the phosphorylated Ser/Thr, and a 2nd FITC-conjugated antibody is used in a detection mix to quantify the phosphorylation signal.
Khaled Alganem1, Robert McCullumsmith et al.
www.sciencedirect.com Current Opinion in Pharmacology (2022)
LaurenWegman‑Points1, Li‑LianYuan
Scientific Reports | (2022)
Isabel C. Lopez-Mejia, Andree Yeramian et al,
Molecular Oncology 17 (2023)